The Bio-Process Systems Alliance (BPSA), the international association of the single-use bioprocessing industry, announces the election of BPSA executive board members and directors-at-large for 2023-2024.
Mark Petrich, PhD, vice president, process development and validation, Krystal Biotech, Inc. is elected BPSA chair; Joseph St. Laurent, head of industry relations and regulatory expert, Solvias, Inc. is elected first vice chair; Todd Kapp, global commercial development director-life sciences, Entegris, Inc., is elected second vice chair and Hernan Parma of Renolit Healthcare and Danielle Arcuri of Qosina, Inc. are elected as directors-at-large.
“I want to congratulate Mark on being elected BPSA Chair,” says BPSA outgoing chair, Jeff Carter, PhD, of Cytiva, whose term ends December 31, 2022, in a press release from the organization. “The BPSA Board represents the entire value chain of the single-use industry, inclusive of resin producers, component manufacturers, system integrators, global OEM suppliers, analytical laboratories and end-users. We are pleased to have an end-user/pharmaceutical manufacturer in the role of BPSA chair for the first time.”
Petrich reportedly has been active with BPSA for over 10 years, including board and executive board service, first with Merck & Co., Inc. and now at Krystal Biotech, Inc. He has served as chair of the BPSA end-user committee, co-authored several BPSA white papers and helped successfully launch the BPSA sustainability committee.
“Under Jeff’s leadership, the Alliance continued to grow and serve the needs of its members and the biopharmaceutical industry. Many of the changes and challenges presented by the COVID-19 pandemic were addressed by single-use technologies and efforts of BPSA member companies,” says Petrich.
Read the press release at www.bpsalliance.org
